FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY

Özyıldız, Ali Gökhan; Cakmak, Huseyin Altug; ÖZAL, Ender; ÖZYÜNCÜ, Nil; ÖNCEL, Can Ramazan; Tokgozoglu, Lale; YAYLA, ÇAĞRI; KÜÇÜK, Murathan; Köse, Nuri; Akboga, Mehmet Kadri

FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY

Türk Geriatri Dergisi

12 6

Yıl: 2017 Cilt: 20 Sayı: 2 Sayfa Aralığı: 73 - 81 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY

Öz:

Introduction: In Turkey, there is a lack of data on the frequency of cardiovascular diseases, riskfactors, co-morbid diseases, and drug usage among the elderly population. We aimed to compile adata of frequency of cardiovascular diseases, cardiovascular risk factors, concomitant diseases, anddrug usage among elderly patients visiting cardiology clinics in Turkey.Materials and Method: This non-interventional, multicenter study evaluated 5694 patientsaged 65 years or older and who were followed up at cardiology clinics. Cardiovascular diseases, riskfactors, co-morbidities, and medication use were surveyed.Results: Mean age of patients was 73.5±6.3 years (males: 49.8%). The frequency rates were73% for hypertension, 28.8% for diabetes mellitus, 35% for hyperlipidemia, 50% for previousmyocardial infarction, 27.3% for atrial fibrillation, and 11.5% for chronic renal failure. The body massindex of participants was 27.7±4.4 kg/m2, systolic blood pressure was 130±18 mmHg, diastolicblood pressure was 77.1±11 mmHg, and resting heart rate was 76±14 bpm, 66.3% of the studypopulation used beta blockers, 71.7% angiotensin system inhibitors, 59.6% diuretics, 7.9% digoxin,30.5% calcium channel blockers, 34% lipid-lowering agents, 71.5% acetylsalicylic acid, and 25.9%oral anticoagulants. The most common non-cardiovascular medications were vitamins (12.3%) andnonsteroidal anti-inflammatory drugs (11.2%).Conclusion: Valuable data of Turkey’s elderly population at cardiology clinics, pertainingto cardiovascular and co-morbid diseases was collected. The identification of risk factors forcardiovascular diseases as well as concomitant diseases, and medication use in elderly patients maylead to interventions that could improve the health of elderly in the general population.

Anahtar Kelime:

KARDİYOLOJİ KLİNİKLERİNDE TAKİP EDİLEN YAŞLI TÜRK NÜFUSUNDA KARDİYOVASKÜLER HASTALIK SIKLIĞI VE İLAÇ KULLANIMI: ELDERTURK ÇALIŞMASI

Öz:

Giriş: Türkiye'deki yaşlı popülasyonda kardiyovasküler hastalık sıklığı, risk faktörleri, ko-morbid hastalıklar ve ilaç kullanımına ait bir veri yoktur. Amacımız, Türkiye'de kardiyoloji kliniklerince takipli yaşlı nüfusta kardiyovasküler hastalık sıklığı, kardiyovasküler risk faktörleri, eşlik eden hastalıklar ve ilaç kullanımları ile ilgili bir veri oluşturmaktır. Gereç ve Yöntem: Çalışmamız müdahalesiz ve çok merkezli bir çalışmadır. Kardiyoloji kliniklerince takip edilen 65 yaş ve üzeri 5694 hasta çalışmaya dahil edilmiştir. Kardiyovasküler hastalıklar, risk faktörleri, eşlik eden hastalıklar ve ilaç kullanımları sorgulanarak kaydedilmiştir. Bulgular: Çalışma popülasyonunda ortalama yaş 73.5±6.3 idi (erkek oranı %49,8). Hipertansiyon %73, diyabet %28,8, hiperlipidemi %35, geçirilmiş miyokard enfarktüsü %50, atrial fibrilasyon %27,3 ve kronik böbrek hastalığı %11,5 oranında görülmekteydi. Çalışmaya katılanların ortalama vücut kitle indeksi 27.7±4.4 kg/m², sistolik kan basıncı 130±18 mmHg, diyastolik kan basıncı 77.1±11 mmHg ve istirahat kalp hızı 76±14 vuru/dakika idi. Çalışma popülasyonunun %66,3'ü beta bloker, %71,7'si anjiyotensin sistem inhibitörleri, %59,6'sı diüretik, %7,9'u digoksin, %30,5'i kalsiyum kanal blokeri, %34'ü lipid düşürücü ajanlar, %71,5'i asetil salisilik asit ve %25,9'u oral antikoagülan kullanmaktaydı. En sık kullanılan kardiyovasküler sistem dışı ilaçlar vitaminler (%12,3) ve non-steroid anti-inflamatuar ilaçlardı (%11,2). Sonuç: Gözlemsel çok merkezli çalışmamızda, yaşlı Türk popülasyonundaki kardiyovasküler ve ko-morbid hastalıklarla ilgili değerli veriler elde ettik. Yaşlı hastalardaki kardiyovasküler hastalıklar için risk faktörlerinin belirlenmesi, eşlik eden hastalıklar ve kullanılan ilaçların tanımlanması, tüm yaşlı nüfusun sağlığı için uygun ve gerekli girişimlerin yapılmasına yardımcı olabilir.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

1. TUIK-National Statistics Department of Turkey-National Health Report of 2014. Turkey in Statistics 2014, publication number: 4380 [Internet]. Available from: http://www.turkstat.gov.tr. Accessed: 02.09.2016.
2. Eurostat Death Statistics Report of 2011. Eurostat Regional Yearbook 2011. Luxembourg: Publications Office of the European Union, 2011. ISBN 978-92- 79-20366-4, doi:10.2785/1392 [Internet]. Available from: http://www.ec.europa.eu/eurostat. Accessed: 02.09.2016.
3. Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients--a prospective cross-sectional study. S Afr Med J 2006;96:1255-9. (PMID: 17252155).
4. European Association for Cardiovascular Prevention & Rehabilitation. Reiner Z, Catapano AL, De Backer G, et al. ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees.ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 2011;32:1769-818. (PMID: 21712404).
5. Onat A, Türkmen S, Karabulut A, Yazıcı M, Can G, Sansoy V. Combined Hypercholesterolemia and Hypertension Among Turkish Adults: Prevalence and Prediction of Cardiovascular Disease Risk (TEKHARF Trial data). Arch Turk Soc Cardiol 2004;32:533-41. (In Turkish).
6. Altun B, Arici M, Nergizoğlu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. Turkish Society of Hypertension and Renal Diseases. J Hypertens 2005;23:1817-1823. (PMID: 16148604).
7. Ozkara A, Turgut F, Kanbay M, Selcoki Y, Akcay A. Population-based cardiovascular risk factors in the elderly in Turkey: a cross-sectional survey. Central European Journal of Medicine 2008;3:173-8. doi:10.2478/s11536-007-0058-7
8. Satman I, Omer B, Tutuncu Y, et al.; TURDEP-II Study Group.Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28:169-80. (PMID: 23407904).
9. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report, National Institutes of Health. Date of publication:1998. Item No: 98-4083. Available from: https://www.nhlbi.nih.gov/files/docs/ guidelines/ obesity_guidelines_archive.pdf. [Internet]. Accessed: 26.09.2016. 81 FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY
10. Pleis JR, Lucas JW. Summary health statistics for U.S. adults: National Health Interview Survey, 2007. Vital Health Stat 10 2009;(240):1-159. (PMID: 19645319).
11. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001;35:1004-9. (PMID:11573845).
12. Lernfelt B, Samuelsson O, Skoog I, Landahl S. Changes in drug treatment in the elderly between 1971 and 2000. Eur J Clin Pharmacol 2003;59: 637-44. (PMID: 12923602).
13. James PA, Oparil S, Carter BL, et al. 2014 EvidenceBased Guideline for the Management of High Blood Pressure in AdultsReport From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-20. (PMID: 24352797).
14. Bushardt RL, Massey EB, Simpson TW, Ariail JC, Simpson KN. Polypharmacy: misleading, but manageable. Clin Interv Aging 2008;3:383-9. (PMID: 18686760).
15. Martínez-Arroyo JL, Gómez-García A, SaucedaMartínez D. Polypharmacy prevalence and potentially inappropriate drug prescription in the elderly hospitalized for cardiovascular disease. Gac Med Mex 2014;150 Suppl 1:29-38. (PMID: 25643675).
16. Bruno JJ, Ellis JJ. Herbal use among US elderly: 2002 National Health Interview Survey. Ann Pharmacother 2005;39:643-8. (PMID: 15741417).
17. Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential interactions between complementary/alternative products and conventional medicines in a Medicare population. Ann Pharmacother 2007;41:1617-24. (PMID:17785609).
18. Nahin RL, Pecha M, Welmerink DB, Sink K, DeKosky ST, Fitzpatrick AL. Ginkgo Evaluation of Memory Study Investigators. Concomitant use of prescription drugs and dietary supplements in ambulatory elderly people. J Am Geriatr Soc 2009;57:1197-1205. (PMID: 19515113).
19. Celestini A, Pulcinelli FM, Pignatelli P, et al. Vitamin E potentiates the antiplatelet activity of aspirin in collagen-stimulated platelets. Haematologica 2002;87:420-6. (PMID:11940487).
20. Ciccone A, Allegra JR, Cochrane DG, Cody RP, Roche LM. Age-related differences in diagnoses within the elderly population. Am J Emerg Med 1998; 16:43-8. (PMID: 9451312).
21. Durukan P, Çevik Y, Yıldız M. Acil Servise Karın Ağrısıyla Başvuran Yaşlı Hastaların Değerlendirilmesi. Turkish Journal of Geriatrics 2005;8:111-4. (In Turkish).
22. Myers S. Patient care. Elderly emergency. Hosp Health Netw 2005;79:24-6. (PMID: 16128313).
23. Baz U, Satar S, Kozacı N, Açıkalın A, Gülen M, Karakurt U. Geriatric Patient Admissions to the Emergency Service. Eurasian J Emerg Med 2014;13:53-7. Doi: 10.5152/jaem.2013.00

APA	ÖZAL E, Cakmak H, YAYLA Ç, Özyıldız A, ÖNCEL C, Akboga M, Köse N, KÜÇÜK M, Tokgozoglu L, ÖZYÜNCÜ N (2017). FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. , 73 - 81.
Chicago	ÖZAL Ender,Cakmak Huseyin Altug,YAYLA ÇAĞRI,Özyıldız Ali Gökhan,ÖNCEL Can Ramazan,Akboga Mehmet Kadri,Köse Nuri,KÜÇÜK Murathan,Tokgozoglu Lale,ÖZYÜNCÜ Nil FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. (2017): 73 - 81.
MLA	ÖZAL Ender,Cakmak Huseyin Altug,YAYLA ÇAĞRI,Özyıldız Ali Gökhan,ÖNCEL Can Ramazan,Akboga Mehmet Kadri,Köse Nuri,KÜÇÜK Murathan,Tokgozoglu Lale,ÖZYÜNCÜ Nil FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. , 2017, ss.73 - 81.
AMA	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. . 2017; 73 - 81.
Vancouver	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. . 2017; 73 - 81.
IEEE	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N "FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY." , ss.73 - 81, 2017.
ISNAD	ÖZAL, Ender vd. "FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY". (2017), 73-81.

APA	ÖZAL E, Cakmak H, YAYLA Ç, Özyıldız A, ÖNCEL C, Akboga M, Köse N, KÜÇÜK M, Tokgozoglu L, ÖZYÜNCÜ N (2017). FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. Türk Geriatri Dergisi, 20(2), 73 - 81.
Chicago	ÖZAL Ender,Cakmak Huseyin Altug,YAYLA ÇAĞRI,Özyıldız Ali Gökhan,ÖNCEL Can Ramazan,Akboga Mehmet Kadri,Köse Nuri,KÜÇÜK Murathan,Tokgozoglu Lale,ÖZYÜNCÜ Nil FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. Türk Geriatri Dergisi 20, no.2 (2017): 73 - 81.
MLA	ÖZAL Ender,Cakmak Huseyin Altug,YAYLA ÇAĞRI,Özyıldız Ali Gökhan,ÖNCEL Can Ramazan,Akboga Mehmet Kadri,Köse Nuri,KÜÇÜK Murathan,Tokgozoglu Lale,ÖZYÜNCÜ Nil FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. Türk Geriatri Dergisi, vol.20, no.2, 2017, ss.73 - 81.
AMA	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. Türk Geriatri Dergisi. 2017; 20(2): 73 - 81.
Vancouver	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY. Türk Geriatri Dergisi. 2017; 20(2): 73 - 81.
IEEE	ÖZAL E,Cakmak H,YAYLA Ç,Özyıldız A,ÖNCEL C,Akboga M,Köse N,KÜÇÜK M,Tokgozoglu L,ÖZYÜNCÜ N "FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY." Türk Geriatri Dergisi, 20, ss.73 - 81, 2017.
ISNAD	ÖZAL, Ender vd. "FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY". Türk Geriatri Dergisi 20/2 (2017), 73-81.